|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
ELB179124 |
| 003 |
FINmELB |
| 005 |
20200520144314.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
760408s1976 ne a sb 111 0 eng d |
| 010 |
|
|
|z 76010396
|
| 020 |
|
|
|z 0444152059 (Amer. Elsevier)
|
| 020 |
|
|
|z 9021940442 (Excerpta Medica)
|
| 020 |
|
|
|z 9780470663318
|
| 020 |
|
|
|a 9780470717899 (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)2151048
|
| 040 |
|
|
|a FINmELB
|c FINmELB
|d FINmELB
|
| 050 |
|
4 |
|a QP603.M6
|b S95 1975
|
| 082 |
0 |
4 |
|a 612/.0151/8
|2 22
|
| 111 |
2 |
|
|a Symposium on Monoamine Oxidase and its Inhibition
|d (1975 :
|c London, England)
|
| 245 |
1 |
0 |
|a Monoamine oxidase and its inhibition
|h [electronic resource] :
|b in honour of Mary L. C. Bernheim.
|
| 260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier/Excerpta Medica/North-Holland,
|c 1976.
|
| 300 |
|
|
|a xii, 415 p. :
|b ill.
|
| 490 |
1 |
|
|a Ciba Foundation symposium ; 39 (new ser.)
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 505 |
0 |
|
|a Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.
|
| 588 |
|
|
|a Description based on metadata supplied by the publisher and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Santa Fe, Arg.: elibro, 2022. Available via World Wide Web. Access may be limited to eLibro affiliated libraries.
|
| 650 |
|
0 |
|a Monoamine oxidase
|v Congresses.
|
| 650 |
|
0 |
|a Monoamine oxidase
|x Inhibitors
|v Congresses.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Bernheim, Molly,
|d 1902-1997.
|
| 797 |
2 |
|
|a elibro, Corp.
|
| 830 |
|
0 |
|a Ciba Foundation symposium ;
|v new ser. 39.
|
| 856 |
4 |
0 |
|u https://elibro.uam.elogim.com/ereader/bidiuam/179124
|z Texto completo
|
| 950 |
|
|
|a eLibro English
|
